J Neurodev Disord
Alzheimer DiseaseAmyloid beta-PeptidesCognitive Dysfunction
Dr. Herminia Diana Rosas, MD
NPI1497840177PAC ID6901885821
- Medicare services, 2024
- 300
- Medicare patients, 2024
- 50
- Part D claims, 2024
- 729
- Publications
- 53
- Hospital affiliations
- 4
- Practice address
- 300 First Avenue, Charlestown, MA 02129
- Practice phone
- Call (617) 720-6400
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Rosas' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Herminia Diana Rosas is a neurologist in Charlestown, Massachusetts
Dr. Rosas practices at Spaulding Rehabilitation Hospital (Boston) in Charlestown, Massachusetts, part of Mass General Brigham.
Dr. Rosas' NPI, 1497840177, was assigned on October 4, 2006. Dr. Rosas graduated from University of Chicago, Pritzker School of Medicine in 1992. Dr. Rosas holds Massachusetts license 151574.
NPI and contact details
- NPI
- 1497840177NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6901885821
- NPI enumeration date
- October 4, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (617) 720-6400
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 60
- Medical school graduation
- 1992
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Herminia Diana Rosas practices at Spaulding Rehabilitation Hospital (Boston) in Charlestown, Massachusetts
Dr. Rosas' primary practice is Spaulding Rehabilitation Hospital (Boston), at 300 First Avenue, Charlestown, MA 02129 in Suffolk County. The practice phone is (617) 720-6400.
- Spaulding Rehabilitation Hospital (Boston)300 First Avenue, Charlestown, MA 02129 · Suffolk CountyPhone(617) 720-6400
Source: Dmand AI Affiliation Data
Dr. Herminia Diana Rosas is affiliated with 7 sites of care and 2 medical groups
Dr. Rosas' primary practice is Spaulding Rehabilitation Hospital (Boston) in Charlestown, Massachusetts, part of Mass General Brigham. Dr. Rosas is also affiliated with Massachusetts General Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Rosas to 2 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.
Massachusetts General HospitalMassachusetts General Physicians Organization (MGPO)2 hospitalsNames with a free account2 group practices and clinicsNames with a free account1 home health agencyName with a free account1 medical groupName with a free account
See all 9 affiliations for Dr. RosasSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Herminia Diana Rosas' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosas practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Spaulding Rehabilitation Hospital (Boston) | Available with a free account |
| +6 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Rosas practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Mass General Brigham and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Herminia Diana Rosas is one of 806 neurologists in Massachusetts
Neurology is Dr. Rosas' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rosas is licensed in Massachusetts.
Specialties and state licenses
- Neurology, MassachusettsPrimary
Neurologists near Dr. Rosas
Counts of neurologists with a Dmand AI profile, by place and practice. Each opens the list.
806neurologists in Massachusetts14neurologists in Charlestown5neurologists at Spaulding Rehabilitation Hospital (Boston)
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Herminia Diana Rosas billed Medicare for 300 services in 2024
CMS data shows 300 Medicare services from Dr. Rosas across 3 procedure codes in 2024, for 50 Medicare patients. Medicare paid $15,538 for them. Every service was in an office.
Medicare services, 2024300
Medicare patients50
Paid by Medicare$15,538
Procedure codes3
Dr. Rosas' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Other services
- 2023: 1272024: 20763%
- Office and hospital visits
- 2023: 702024: 7811%
- Tests and treatments
- 2023: 172024: 1512%
Dr. Rosas compared with the Massachusetts median for neurologists, 2024
- Dr. Rosas
- Massachusetts median
- Medicare services
- 300vs 314Close to median
- Medicare patients
- 50vs 17872% below
- Part D claims
- 622vs 2702.3 times
Medians across 741 neurologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Rosas' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Rosas?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rosas and other neurologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Herminia Diana Rosas treated 50 Medicare patients in 2024, average age 58
CMS counts 50 Medicare patients who saw Dr. Rosas in 2024. The largest group is under 65, with 36 patients. 44% of them have high cholesterol, and 38% have mood disorders. 72% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Rosas' median patient age at 57, with 51% women.
Medicare patients, 202450
Average age58
Average risk score1.00
Also on Medicaid72%
Dr. Rosas' Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Rosas' Medicare patients by sex, 2024
- Women2346%
- Men2754%
Chronic conditions among Dr. Rosas' Medicare patients, 2024
- High cholesterol44%
- Mood disorders38%
- Depression32%
- Alzheimer's and dementia28%
- Anxiety28%
- Osteoporosis26%
- Arthritis24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Rosas' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 57
Patient panel by sex, all payers
- Women51%
- Men47%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Herminia Diana Rosas wrote 729 Medicare Part D claims in 2024
In 2024, Dr. Rosas wrote 729 Medicare Part D claims for 61 patients. 93% of them were for generic drugs. CMS names the drug for 622 of them, across 22 drugs with 11 or more claims each, at $149,881 in total drug cost. In 2023, CMS named 576 claims across 24 drugs.
Part D claims, 2024729
Drugs named by CMS22
Total drug cost$149,881
Part D patients61
Dr. Rosas' Part D claims by kind of drug, 2024
- Generic676 claims93%
- Brand-name53 claims7%
Dr. Rosas' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Rosas' Part D claims, 2024
- Antipsychotics, patients 65 and over6%42 of 729 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5762024: 6228%
Drugs named by CMS: 22 in 2024, 24 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Herminia Diana Rosas takes part in Medicare
Dr. Rosas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find neurologists like Dr. Rosas by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Herminia Diana Rosas has 53 publications on record
Dmand AI links 53 papers to Dr. Rosas, published from 2016 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Alzheimer Disease, Down Syndrome and Huntington Disease. Dr. Rosas has published most often in Alzheimers Dement (Amst). Dr. Rosas' most frequent co-authors are Florence Lai, MD, Ira T. Lott, MD and Michael S. Rafii, MD, PhD.
Papers53
Years published2016 to 2025
Dr. Rosas' papers by year, 2016 to 2025
Topics Dr. Rosas writes about most
- Alzheimer Disease
- Down Syndrome
- Huntington Disease
- Positron-Emission Tomography
- Amyloid beta-Peptides
- tau Proteins
- Brain
- Magnetic Resonance Imaging
Dr. Rosas' most frequent co-authors
- Florence Lai, MD33 shared papers
- Ira T. Lott, MD23 shared papers
- Michael S. Rafii, MD, PhD5 shared papers
Recent publications by Dr. Rosas
Alzheimers Dement
Alzheimer DiseaseAmyloid beta-PeptidesBrain
Alzheimer DiseaseAmyloid beta-PeptidesDown Syndrome
See who Dr. Rosas researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rosas works with, so you can find a warm path to the right neurologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Herminia Diana Rosas received $14,232 in industry payments from 2021 to 2025
CMS Open Payments shows 5 general payments to Dr. Rosas from 3 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 99% of the total. Neurocrine BioSciences, Inc. paid the most, $11,185.
General payments to Dr. Rosas by program year, 2021 to 2025
General payments to Dr. Rosas by kind, 2021 to 2025
$14.2Kin total
- Consulting fees$14,05499%
- Food and beverage$1781%
Companies that paid Dr. Rosas the most, 2021 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Herminia Diana Rosas graduated from University of Chicago, Pritzker School of Medicine
Dr. Rosas graduated from University of Chicago, Pritzker School of Medicine in 1992.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Herminia Diana Rosas's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Herminia Diana Rosas
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Herminia Diana Rosas' NPI number?
Dr. Herminia Diana Rosas' NPI number is 1497840177. It was assigned on October 4, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Herminia Diana Rosas?
Dr. Herminia Diana Rosas is a neurologist in Charlestown, Massachusetts. The primary specialty in the NPI Registry is Neurology Physician (taxonomy code 2084N0400X).
Where does Dr. Herminia Diana Rosas practice?
Dr. Rosas practices at 300 First Avenue, Charlestown, MA 02129. Dr. Rosas' primary practice is Spaulding Rehabilitation Hospital (Boston) in Charlestown, Massachusetts, part of Mass General Brigham. Dmand AI also links Dr. Rosas to 2 hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group.
What is Dr. Herminia Diana Rosas' office phone number?
The practice phone on file for Dr. Rosas is (617) 720-6400.
What is Dr. Herminia Diana Rosas' medical license number?
Dr. Rosas holds Massachusetts license 151574.
Which hospitals is Dr. Herminia Diana Rosas affiliated with?
Dr. Rosas practices at Spaulding Rehabilitation Hospital (Boston) in Charlestown, Massachusetts. Dr. Rosas is also affiliated with Massachusetts General Hospital. Dmand AI links Dr. Rosas to 2 more hospitals.
What medical group is Dr. Herminia Diana Rosas part of?
Dr. Rosas is linked to Massachusetts General Physicians Organization (MGPO). Dmand AI links Dr. Rosas to 1 more medical group.
Does Dr. Herminia Diana Rosas accept Medicare?
Yes. CMS data shows Dr. Rosas billed Medicare for 300 services in 2024, and Dr. Rosas accepts Medicare assignment.
How many Medicare patients does Dr. Herminia Diana Rosas see?
CMS counts 50 Medicare patients who saw Dr. Rosas in 2024, with an average age of 58.
What services does Dr. Herminia Diana Rosas bill to Medicare?
In 2024, Dr. Rosas' most billed Medicare services were medicare service (G2212), office visit, established patient (99215) and health assessment (96116).
Show 6 more questionsShow fewer questions
Where did Dr. Herminia Diana Rosas go to medical school?
Dr. Rosas graduated from University of Chicago, Pritzker School of Medicine in 1992.
What drugs does Dr. Herminia Diana Rosas prescribe most?
In 2024 Medicare Part D data, Dr. Rosas' most prescribed drugs by claims were Risperidone, Aripiprazole and Memantine HCl.
Has Dr. Herminia Diana Rosas received payments from drug or device companies?
CMS Open Payments shows $14,232 in general payments to Dr. Rosas from 3 companies from 2021 to 2025. The largest total came from Neurocrine BioSciences, Inc.
How long has Dr. Herminia Diana Rosas been practicing?
Dr. Rosas graduated from medical school in 1992, 34 years ago.
Does Dr. Herminia Diana Rosas do research?
Dmand AI links 53 publications to Dr. Rosas, published from 2016 to 2025.
Who does Dr. Herminia Diana Rosas publish with?
Dr. Rosas' most frequent co-authors are Florence Lai, MD (33 shared papers), Ira T. Lott, MD (23 shared papers) and Michael S. Rafii, MD, PhD (5 shared papers).
Selling to neurology practices?
See neurologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card